您的位置: 首页 > 农业专利 > 详情页

PHARMACOLOGICAL VITREOLYSIS USING TRUNCATED PLASMIN
专利权人:
发明人:
申请号:
HK11112982.2
公开号:
HK1158512A
申请日:
2006.03.28
申请国别(地区):
HK
年份:
2012
代理人:
摘要:
Prevent or controlled the method for object disease of eye or disease complication, this method comprises makes vitreous body and/or aqueous humor contact with the compositions of the form fibrinolysin that comprises truncate (the catalyst structure domain TPCD that comprises fibrinolysin).TPCD includes, but are not limited to, little fibrinolysin (miniplasmin), fento lyase and their derivant and variant.Method of the present invention can be used to reduce Vitrea viscosity, make liquefaction of vitreous, induce rear vitreous body break away from, reduce eye hemorrhage, remove or reduce to the virose material of eyes, from ophthalmic remove or reduce allogenic material, increase to eye give the compositions of clothes diffusion, reduce extraretinal angiogenesis and above-mentioned any combination.This method can be used when not having vitrectomy or assisting as vitrectomy.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充